1. Home
  2. DKI vs XAIR Comparison

DKI vs XAIR Comparison

Compare DKI & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DKI

DarkIris Inc. Class A Ordinary Shares

N/A

Current Price

$0.47

Market Cap

8.7M

Sector

N/A

ML Signal

N/A

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$0.56

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DKI
XAIR
Founded
2018
2011
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
10.1M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
DKI
XAIR
Price
$0.47
$0.56
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
8.6M
308.2K
Earning Date
05-11-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.09
EPS
N/A
N/A
Revenue
N/A
$3,705,000.00
Revenue This Year
N/A
$122.00
Revenue Next Year
N/A
$58.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
219.67
52 Week Low
$0.28
$0.15
52 Week High
$11.80
$3.78

Technical Indicators

Market Signals
Indicator
DKI
XAIR
Relative Strength Index (RSI) 52.68 38.93
Support Level $0.35 $0.15
Resistance Level $0.80 $0.82
Average True Range (ATR) 0.12 0.08
MACD 0.00 -0.01
Stochastic Oscillator 20.44 36.33

Price Performance

Historical Comparison
DKI
XAIR

About DKI DarkIris Inc. Class A Ordinary Shares

Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Share on Social Networks: